1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Brain Implants Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Brain Implants Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Brain Implants Market Regional Analysis
6.2 North America Brain Implants Market Revenue 2020-2030 (US$ Million)
6.3 North America Brain Implants Market Forecast Analysis
7. North America Brain Implants Market Analysis – by Treatment
7.1 Deep Brain Stimulation
- 7.1.1 Overview
- 7.1.2 Deep Brain Stimulation: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Spinal Cord Stimulation
- 7.2.1 Overview
- 7.2.2 Spinal Cord Stimulation: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Vagus Nerve Stimulator
- 7.3.1 Overview
- 7.3.2 Vagus Nerve Stimulator: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Invasive and Non-Invasive Brain-Computer Interface
- 7.4.1 Overview
- 7.4.2 Invasive and Non-Invasive Brain-Computer Interface: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Responsive Neurostimulation for Seizures
- 7.5.1 Overview
- 7.5.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Auditory Brainstem Implant
- 7.6.1 Overview
- 7.6.2 Auditory Brainstem Implant: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.7 Ophthalmic Aid/Implant
- 7.7.1 Overview
- 7.7.2 Ophthalmic Aid/Implant: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Brain Implants Market Analysis – by Application
8.1 Chronic Pain
- 8.1.1 Overview
- 8.1.2 Chronic Pain: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Parkinson\'s Disease
- 8.2.1 Overview
- 8.2.2 Parkinson\'s Disease: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Alzheimer\'s Disease
- 8.3.1 Overview
- 8.3.2 Alzheimer\'s Disease: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Epilepsy
- 8.4.1 Overview
- 8.4.2 Epilepsy: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Essential Tremor
- 8.5.1 Overview
- 8.5.2 Essential Tremor: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Depression
- 8.6.1 Overview
- 8.6.2 Depression: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Dystonia
- 8.7.1 Overview
- 8.7.2 Dystonia: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Amyotrophic Lateral Sclerosis
- 8.8.1 Overview
- 8.8.2 Amyotrophic Lateral Sclerosis: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.9 Neurofibromatosis 2
- 8.9.1 Overview
- 8.9.2 Neurofibromatosis 2: North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Brain Implants Market Analysis – by End User
9.1 Hospitals and Specialized Clinics/Neurological Centers
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialized Clinics/Neurological Centers : North America Brain Implants Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Brain Implants Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Brain Implants Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 North America Brain Implants Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Brain Implants Market Breakdown, by Treatment
- 10.2.1.1.2 US: North America Brain Implants Market Breakdown, by Application
- 10.2.1.1.3 US: North America Brain Implants Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Brain Implants Market Breakdown, by Treatment
- 10.2.1.2.2 Canada: North America Brain Implants Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Brain Implants Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Brain Implants Market Breakdown, by Treatment
- 10.2.1.3.2 Mexico : North America Brain Implants Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Brain Implants Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Blackrock Microsystems Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BrainGate
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Fisher Wallace Laboratories Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Functional Neuromodulation Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medtronic Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Neuralink Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NeuroPace Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 NeuroSky Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Neurospine LLC
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 ONWARD Medical NV
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Paradromics Inc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Renishaw Plc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Synchron Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations